| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 05/04/2006 | US20060094016 Determination of methylation of nucleic acid sequences |
| 05/04/2006 | US20060094015 Methods and materials for using chemical compounds as a tool for nucleic acid storage on media of nucleic acid purification systems |
| 05/04/2006 | US20060094014 Nucleic acid supported protein complementation |
| 05/04/2006 | US20060094013 Salt-inducible kinases 2 and use thereof |
| 05/04/2006 | US20060094012 Polymorphisms for predicting disease and treatment outcome |
| 05/04/2006 | US20060094011 Method for altering fatty acid composition of milk |
| 05/04/2006 | US20060094010 Methods and compositions for analyzing comprised sample using single nucleotide polymorphism panels |
| 05/04/2006 | US20060094009 Method for the characterisation of nucleic acid molecules |
| 05/04/2006 | US20060094008 Nucleic acid amplification primers for detecting cytokeratins and examination method with the use of the primers |
| 05/04/2006 | US20060094007 Method of identifying pancreatic ductal carcinoma-specific gene using pancreatic ductal cells, method of testing for pdc using said genes, and method of screening pharmaceutical candidate compounds for treating or preventing pdc |
| 05/04/2006 | US20060094006 Immunotherapy regimens in hiv-infected patients |
| 05/04/2006 | US20060094005 Contacting the sample solution with a dipstick to cause sample solution to move by capillary action to a capture zone of the dipstick thereby allowing target nucleic acid in the sample solution to be captured and detected at the capture zone |
| 05/04/2006 | US20060094004 Micro-reactor, biological material inspection device, and microanalysis system |
| 05/04/2006 | US20060094003 Acetylcholine-dependent current as a novel ionic target for atrial fibrillation |
| 05/04/2006 | US20060094002 Eukaryotic biosensor making use of a calcium regulated light emitting enzyme |
| 05/04/2006 | US20060094001 Method and device for image processing and learning with neuronal cultures |
| 05/04/2006 | US20060094000 Destructible surfactants and uses thereof |
| 05/04/2006 | US20060093686 Lectin for checking blood type, blood type checking reagent containing the lectin, and method of checking blood type using the blood type checking reagent |
| 05/04/2006 | US20060093621 Brucella melitensis strain deficient in the carboxyl-terminal proteolytic processing activity of a tail-specific protease caused by a nucleotide sequence deletion within a tspA gene; vaccine for swine, reindeer, cattle and humans; genetic engineering |
| 05/04/2006 | US20060093620 Modified poxviruses, including modified smallpox virus vaccine based on recombinant drug-sensitive vaccinia virus, and new selection methods |
| 05/04/2006 | US20060093616 Process for vaccinating eucaryotic hosts and for protecting against SARS-CoV infection |
| 05/04/2006 | US20060093611 from mammalian chondrocyte progenitor cells expressing mechanosensitive TWIK-related potassium (TREK) ion channels; biocompatability, in vitro |
| 05/04/2006 | US20060093608 Low molecular weight protein tyrosine phosphatase (lmw-ptp) as a diagnostic and therapeutic target |
| 05/04/2006 | US20060093604 Method of treatment and prophylaxis |
| 05/04/2006 | US20060093596 Genomic approach to identification of novel broad-spectrum antimicrobial peptides from bony fish |
| 05/04/2006 | US20060093585 Providing mammalian cell contacted with agent and adeno-associated virus (AAV), identifying agent that when contacted with mammalian cell enhances AAV transduction after viral binding to membrane of contacted mammalian cell and before second strand synthesis which yields expressible form of viral genome |
| 05/04/2006 | US20060093575 Oxaliplatin anti-resistance agent |
| 05/04/2006 | US20060093515 Automated solution generator |
| 05/04/2006 | US20060092339 Programmable mask and method for fabricating biomolecule array using the same |
| 05/04/2006 | DE19824900B4 DNA-Nachweis über einen Strangreassoziationskomplex DNA evidence of a Strangreassoziationskomplex |
| 05/04/2006 | DE10320602B4 Verfahren zur Identifizierung einer möglichen Modifikation von mindestens einem biologischen Parameter unter Verwendung von jungen und alten lebenden Zellen A method for identifying a possible modification of at least one biological parameters using young and old living cells |
| 05/04/2006 | DE10260431B4 Verfahren zur selbstjustierenden Immobilisierung lebender Zellen auf einem Substrat auf Silizium-Basis A process for self-aligning the immobilization of living cells on a substrate based on silicon |
| 05/04/2006 | DE102004051573A1 Waste liquid treatment in cartridges comprises injecting a liquid absorbent into a container, which is placed in a sealed chemical reaction cartridge, absorbing the chemicals and gelling dangerous substances such as pathogenic bacteria |
| 05/04/2006 | CA2592752A1 Use of the slug gene or the replication, transcription or expression products thereof in the identification, diagnosis, prevention or treatment of the spread of cancer and/or the development of metastasis |
| 05/04/2006 | CA2586182A1 Method of gene screening with yeast that inducibly expresses ergosterol biosynthetic enzyme |
| 05/04/2006 | CA2585970A1 Mammalian genes involved in infection |
| 05/04/2006 | CA2585831A1 Applications of nucleic acid fragments |
| 05/04/2006 | CA2585244A1 Identification marker responsive to interferon therapy for renal cell cancer |
| 05/04/2006 | CA2585200A1 Infrared measurement for the rapid enumeration of microbial concentrations |
| 05/04/2006 | CA2585175A1 Pharmaceutical compositions comprising cb1 cannabinoid receptor antagonists and potassium channel openers for the treatment of diabetes mellitus type i, obesity and related conditions |
| 05/04/2006 | CA2585025A1 Dynamic genomic deletion expansion and formulation of molecular marker panels for integrated molecular pathology diagnosis and characterization of tissue, cellular fluid, and purefluid specimens |
| 05/04/2006 | CA2585011A1 Chlamydia trachomatis antigens for vaccine and diagnostic use |
| 05/04/2006 | CA2584989A1 Molecular analysis of cellular fluid and liquid cytology specimens for clinical diagnosis, characterization, and integration with microscopic pathology evaluation |
| 05/04/2006 | CA2584923A1 A method of nucleic acid typing for selecting registered donors for cross-matching to transfusion recipients |
| 05/04/2006 | CA2584784A1 Methods and kits for detecting mutations |
| 05/04/2006 | CA2584780A1 Tomato plants having higher levels of resistance to botrytis |
| 05/04/2006 | CA2584768A1 Repair of nucleic acids for improved amplification |
| 05/04/2006 | CA2584741A1 Methods and kits for detecting germ cell genomic instability |
| 05/04/2006 | CA2584723A1 Enhanced amplifiability of minute fixative-treated tissue samples, minute stained cytology samples, and other minute sources of dna |
| 05/04/2006 | CA2584489A1 Kaspp (lrrke) gene, its production and use for the detection and treatment of neurodegenerative disorders |
| 05/04/2006 | CA2583729A1 Stable metal/conductive polymer composite colloids and methods for making and using the same |
| 05/04/2006 | CA2583677A1 Tnf-like weak inducer of apoptosis (tweak) receptor binding domain |
| 05/04/2006 | CA2583193A1 Double hybrid system based on gene silencing by transcriptional interference |
| 05/04/2006 | CA2579034A1 Klf6 alternative splice forms and a germline klf6 dna polymorphism associated with increased cancer risk |
| 05/04/2006 | CA2548534A1 Methods for determining microbial contamination of allograft products |
| 05/04/2006 | CA2525358A1 Nucleic acid labeling methods |
| 05/03/2006 | EP1653385A2 Method of designing probe from polynucleotide group comprising plurality of polynucleotides |
| 05/03/2006 | EP1652937A2 Diagnostic test fo collie eye anomaly |
| 05/03/2006 | EP1652936A2 cDNA for human methylenetetrahydrofolate reductase |
| 05/03/2006 | EP1652935A1 Methods using mitochondrial nucleic acid for determining a health status of an individual |
| 05/03/2006 | EP1652934A1 Improved method of amplifying atp and use thereof |
| 05/03/2006 | EP1652933A1 Method for determining the ecotoxicological effect of solid phase adsorbed and/or water dissolved hazardous waste in a matrix and test kit for performing the said method |
| 05/03/2006 | EP1652930A1 Botrytis-resistant tomato plants |
| 05/03/2006 | EP1652927A2 Campylobacter glycosyltransferases for biosynthesis of gangliosides and ganglioside mimics |
| 05/03/2006 | EP1652923A1 Gene overexpressed in cancer |
| 05/03/2006 | EP1652919A1 Improvements to ribosome display |
| 05/03/2006 | EP1652918A2 Methods for detecting protein interactions using conformationally constrained peptides |
| 05/03/2006 | EP1652852A1 Nucleoside capable of releasing functional unit through oxidation and process for producing oligonucleotide containing the same |
| 05/03/2006 | EP1652839A2 Drug efflux pump inhibitor |
| 05/03/2006 | EP1651963A2 Monocarboxylate transporters expressed in cancer cells |
| 05/03/2006 | EP1651962A1 Analytical method for pancreatin and comparable compositions |
| 05/03/2006 | EP1651956A2 Melks as modifiers of the rac pathway and methods of use |
| 05/03/2006 | EP1651780A2 Thiamin production by fermentation |
| 05/03/2006 | EP1651779A2 Method for rapid identification of alternative splicing |
| 05/03/2006 | EP1651778A1 Methods and compositions related to the use of sequence-specific endonucleases for analyzing nucleic acids under non-cleaving conditions |
| 05/03/2006 | EP1651777A2 Use single nucleotide polymorphsm in the coding region of the porcine leptin receptor gene to enhance pork production |
| 05/03/2006 | EP1651776A2 Method for the reverse transcription and/or amplification of nucleic acids |
| 05/03/2006 | EP1651775A2 Breast cancer survival and recurrence |
| 05/03/2006 | EP1651774A2 Use of polymorphisms in human oatp-c associated with an effect on statin pharmacokinetics in humans in statin therapy |
| 05/03/2006 | EP1651773A1 Diagnostics of diarrheagenic escherichia coli (dec) and shigella spp. |
| 05/03/2006 | EP1651772A1 Breast cancer signatures |
| 05/03/2006 | EP1651759A1 Methods and compositions for determination of glycated proteins |
| 05/03/2006 | EP1651758A1 Method for producing l-lysine or l-threonine using escherichia bacteria having attnuated malic enzyme activity |
| 05/03/2006 | EP1651751A2 Engineered proteases for affinity purification and processing of fusion proteins |
| 05/03/2006 | EP1651750A2 Lactobacillus acidophilus nucleic acids encoding fructo-oligosaccharide utilization compounds and uses thereof |
| 05/03/2006 | EP1651674A2 Ups as modifiers of the beta catenin pathway and methods of use |
| 05/03/2006 | EP1651225A1 High throughput assay systems and methods for identifying agents that alter surface expression of integral membrane proteins |
| 05/03/2006 | EP1651095A2 ErbB RECEPTOR METHODS AND KITS FOR MONITORING CHEMOTHERAPY RESISTANCE |
| 05/03/2006 | EP1501944A4 Amplification of dna to produce single-stranded product of defined sequence and length |
| 05/03/2006 | EP1490486A4 Method of identifying genes controlling diferentiation |
| 05/03/2006 | EP1488007A4 Gene expression profiling in biopsied tumor tissues |
| 05/03/2006 | EP1448986B1 Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides |
| 05/03/2006 | EP1425046A4 Wild-type ras as a cancer therapeutic agent |
| 05/03/2006 | EP1389129A4 Methods of treating respiratory conditions |
| 05/03/2006 | EP1383861B1 Filtration assembly |
| 05/03/2006 | EP1356080B1 Detection and identification of groups of bacteria |
| 05/03/2006 | EP1244349B1 Pyrophosphatase stress-related proteins and methods of use in plants |
| 05/03/2006 | EP1240822B1 Diabetes onset model mammal |
| 05/03/2006 | EP1236044B1 Diagnosing and treating arthritic disorders |
| 05/03/2006 | EP1236034A4 Biosensing using surface plasmon resonance |